J. Swierkot
发表论文 2 篇
代表论文
- POS0540 Long-Term Safety and Efficacy of Upadacitinib or Adalimumab in Patients With Rheumatoid Arthritis: 7-Year Data From the SELECT-COMPARE Study (2025 · Annals of the Rheumatic Diseases)
- Long-Term Safety and Efficacy of Upadacitinib or Adalimumab in Patients With Rheumatoid Arthritis: 7-Year Data From the SELECT-COMPARE Study (2025 · XLII Congresso Brasileiro de Reumatologia)